Search
Search Funnelback University
1 -
10 of
23
search results for `treatment of lupus`
Fully-matching results
-
Dr David Jayne | Cambridge Immunology Network
https://www.immunology.cam.ac.uk/Networkdirectory/jayne23 Feb 2024: Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... 33: Smith RM, Jones RB, Jayne DR. Progress in treatment of ANCA-associated vasculitis. -
Professor David Jayne - Experimental Medicine and Immunotherapeutics…
https://emit.medschl.cam.ac.uk/people/investigators/dr-david-jayne/23 Feb 2024: Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Ann Rheum Dis. ... Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment. -
ADVANCING RESEARCH IN RENAL AUTOIMMUNITY A COLLABORATIVE SYMPOSIUM…
https://otr.medschl.cam.ac.uk/files/8_emi_autoimmunity_schedule_230120.pdf24 Nov 2022: He has organised international collaborative studies to develop consensus classifications of lupus glomerulonephritis, IgA nephropathy and. ... He is responsible for early phase studies of a rapidly expanding portfolio of new compounds under development -
PPL number: | Granted: 10 Jun 19 | Amended: ...
https://www.ubs.admin.cam.ac.uk/system/files/public/provision_of_an_outsourced_drug_discovery_platform_for_diseases_with_an_inflammatory_component_nts_expires2022_redacted.pdf13 Sep 2021: i) Avoidance, prevention, diagnosis or treatment of disease, ill-health or abnormality, or theireffects, in man, animals or plants. ... disease. For example we breed mice that have been genetically modified as a model of lupus. -
Insights into how KAP1 silences viral origin DNA in our genomes - MRC …
https://www2.mrc-lmb.cam.ac.uk/insights-into-how-kap1-silences-viral-origin-dna-in-our-genomes/10 Jul 2019: geographic atrophy, and lupus. ... An improved understanding of how KAP1 functions in healthy individuals could suggest new strategies for treatment of these diseases. -
New drug Benlysta in Lupus treatment - MRC Laboratory of Molecular…
https://www2.mrc-lmb.cam.ac.uk/new-drug-benlysta-in-lupus-treatment/15 Jun 2011: Search this website. New drug Benlysta in Lupus treatment. New drug Benlysta in Lupus treatment. ... Published on. 15 June, 2011. “Benlysta emerges as a direct approach in lupus treatment. -
Human antibody approved for treatment of lupus - MRC Laboratory of…
https://www2.mrc-lmb.cam.ac.uk/human-antibody-approved-for-treatment-of-lupus/11 Mar 2011: Search this website. Human antibody approved for treatment of lupus. Human antibody approved for treatment of lupus. ... Food and Drug Administration. It is the first new drug treatment for lupus in 50 years, and the second human therapeutic antibody, -
Human Antibodies developed for Treatment of Lupus and Anthrax - MRC…
https://www2.mrc-lmb.cam.ac.uk/human-antibodies-developed-for-treatment-of-lupus-and-anthrax/31 Jul 2009: Search this website. Human Antibodies developed for Treatment of Lupus and Anthrax. ... Human Antibodies developed for Treatment of Lupus and Anthrax. Published on. -
Fellow partners with AstraZeneca to advance the treatment of lupus |…
https://www.caths.cam.ac.uk/lupusSearch. Home. Fellow partners with AstraZeneca to advance the treatment of lupus. ... CAR T cell therapy with conventional cytotoxic CD8+ T cells are already having transformative impact in the treatment of patients with cancers of the immune system. -
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/4345
https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/4345
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.